Rapivab

Product NDC: 61364-181
Requested package NDC: 61364-181-03
11-digit product format: 613640181
Labeler code: 61364
Product ID: 61364-181_905b7a99-4ba6-4e95-b4e4-a843ddbb20b0
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: peramivir
Dosage form: SOLUTION
Route: INTRAVENOUS
Labeler: Seqirus USA Inc.
Application: NDA206426
Marketing category: NDA
Marketing start: 2014-12-20
Marketing end: 0000-00-00
Substance: PERAMIVIR
Active strength: 600 mg/60mL
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	61364-181	61364-181-03	I	Inactivated by FDA		2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 19 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source date	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	`8dfbde2a14a4…`	`c9ff85d89658…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N206426-001	RAPIVAB	PERAMIVIR	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS		RLD, RS	2014-12-19

Orange Book patents#

Current patent rows page 1 of 1 · 5 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Submission date
N206426-001	10391075	2027-02-12	U-2622	2019-09-25
N206426-001	10391075	2027-02-12	U-3069	2019-09-25
N206426-001	8778997	2027-05-07	U-1627	2015-01-13
N206426-001	8778997	2027-05-07	U-2622	2015-01-13
N206426-001	8778997	2027-05-07	U-3069	2015-01-13

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	N206426-001	RAPIVAB	200MG/20ML (10MG/ML)	SOLUTION / INTRAVENOUS	RLD, RS	2014-12-19	`cb3db0bc1861…`

Observed Orange Book patent history#

Patent history page 1 of 6 · 215 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Submission date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206426-001	10391075	2027-02-12	U-2622	2019-09-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206426-001	10391075	2027-02-12	U-3069	2019-09-25	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206426-001	8778997	2027-05-07	U-2622	2015-01-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206426-001	8778997	2027-05-07	U-1627	2015-01-13	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N206426-001	8778997	2027-05-07	U-3069	2015-01-13	`5bbf6a4d5a75…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N206426-001	NCE	2019-12-19	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N206426-001	NPP	2020-09-20	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N206426-001	NPP	2020-09-20	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N206426-001	NPP	2020-09-20	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N206426-001	NCE	2019-12-19	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N206426-001	NPP	2020-09-20	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N206426-001	NCE	2019-12-19	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N206426-001	NPP	2020-09-20	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N206426-001	NCE	2019-12-19	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N206426-001	NPP	2020-09-20	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
90fc134d-a739-4fd1-b7e8-f9aaabd24b77	Product name	1	20150316

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
61364-181-03	2021-07-23	C162847	48780-1	c7ccaba7-0ff0-fd44-e053-dadaa90aa01b	These highlights do not include all the information needed to use RAPIVAB safely and effectively. See full prescribing information for RAPIVAB. RAPIVAB ® (peramivir injection), for intravenous use Initial U.S. Approval: [2014]

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
61364-181-01	Rapivab	20 mL in 1 VIAL, GLASS	SOLUTION	20		7
61364-181-03	Rapivab	3 in 1 CARTON	SOLUTION	3		7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
61364-181-01	ML - Milliliter	61364-181	66173613-ff45-49b6-bb5f-bf3cd2a70494	1	2015-01-05
61364-181-03	ML - Milliliter	61364-181	929831d0-4474-4b87-9a3a-7b79a9b33101	1	2015-01-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Peramivir	ACTIVE INGREDIENT	QW7Y7ZR15U	RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.]	2
Peramivir Anhydrous	ACTIVE MOIETY	9ZS94HQO3B	RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.]	2
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.]	2
Sodium Chloride	INACTIVE INGREDIENT	451W47IQ8X	RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.]	2
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.]	2
Water	INACTIVE INGREDIENT	059QF0KO0R	RAPIVAB (PERAMIVIR) SOLUTION [BIOCRYST PHARMACEUTICALS, INC.]	2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
61364-181	RAPIVAB (PERAMIVIR) SOLUTION [SEQIRUS USA INC.]	7	Legacy NDC, 2 package rows	20200626_7fdedaec-9e53-4a37-a4e4-a301c8a251b8.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
QW7Y7ZR15U	PERAMIVIR	1041434-82-5	PERAMIVIR

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1598082	peramivir 200 MG in 20 ML Injection	PSN	7fdedaec-9e53-4a37-a4e4-a301c8a251b8	7
876203	Rapivab 200 MG in 20 ML Injection	PSN	7fdedaec-9e53-4a37-a4e4-a301c8a251b8	7
876203	20 ML peramivir 10 MG/ML Injection [Rapivab]	SBD	7fdedaec-9e53-4a37-a4e4-a301c8a251b8	7
1598082	20 ML peramivir 10 MG/ML Injection	SCD	7fdedaec-9e53-4a37-a4e4-a301c8a251b8	7
1598082	peramivir 200 MG per 20 ML Injection	SY	7fdedaec-9e53-4a37-a4e4-a301c8a251b8	7
876203	Rapivab 200 MG per 20 ML Injection	SY	7fdedaec-9e53-4a37-a4e4-a301c8a251b8	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
61364-181-03	61364018103	3 VIAL, GLASS in 1 CARTON (61364-181-03) > 20 mL in 1 VIAL, GLASS (61364-181-01)	2014-12-20	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Rapivab	Seqirus USA Inc. \| Alcami Missouri Corporation \| Cilag Ag \| Eurofins Lancaster Laboratories Inc. \| Galbraith Labs Inc. \| Jubilant HollisterStier LLC \| Patheon Manufacturing Services LLC \| Siegfried USA, LLC	2020-06-17	HUMAN PRESCRIPTION DRUG LABEL	7